Filing Details
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
8k filedNASDAQ:BMRN
BIOMARIN PHARMACEUTICAL INC (BMRN) Reports Material Event to SEC
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
At publication ·
What changed
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- BioMarin Pharmaceutical filed a Form 8-K with the SEC on August 18, 2026, disclosing a material event that shareholders should be aware of, though the specific nature of the event is not detailed in this filing summary.
- The company's stock was trading at $66.99 with a market capitalization of $10.2 billion at the time of the disclosure.
Market Context
BIOMARIN PHARMACEUTICAL INC's stock currently trades at $66.99 with a market capitalization of $10.2B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for BIOMARIN PHARMACEUTICAL INC's stock.
All SEC filings for BIOMARIN PHARMACEUTICAL INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BMRN Stock Page
Frequently Asked Questions
Where can I read BMRN's SEC filings?
Browse all filings on our BMRN SEC filings page.
What types of SEC filings does BIOMARIN PHARMACEUTICAL INC file?
Public companies like BIOMARIN PHARMACEUTICAL INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
